3D Global Biotech Inc. (6808.TWO)
TWD 49.15
(-19.82%)
TWD 49.15
(-19.82%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 5.27 Million TWD | -1.27% |
| 2022 | 69 Million TWD | 7.8% |
| 2021 | 64.01 Million TWD | 15.76% |
| 2020 | 55.29 Million TWD | 32.84% |
| 2019 | 41.62 Million TWD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 18.43 Million TWD | 16.52% |
| 2024 Q2 | 18.43 Million TWD | 0.0% |
| 2023 Q4 | 15.82 Million TWD | 0.0% |
| 2023 Q3 | 15.82 Million TWD | -8.57% |
| 2023 FY | 68.12 Million TWD | -1.27% |
| 2023 Q1 | 17.3 Million TWD | -33.12% |
| 2023 Q2 | 17.3 Million TWD | 0.0% |
| 2022 FY | 69 Million TWD | 7.8% |
| 2022 Q3 | 25.87 Million TWD | 0.0% |
| 2022 Q4 | 25.87 Million TWD | 0.0% |
| 2021 FY | 64.01 Million TWD | 15.76% |
| 2020 FY | 55.29 Million TWD | 32.84% |
| 2019 FY | 41.62 Million TWD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Anti-Microbial Savior BioteQ Co., Ltd | 329 Thousand TWD | -1503.04% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | 127.67 Million TWD | 95.869% |
| Level Biotechnology Inc. | 151.99 Million TWD | 96.53% |
| Sagittarius Life Science Corp | 135.85 Million TWD | 96.118% |
| NeoCore Technology Co., Ltd. | 75.85 Million TWD | 93.048% |
| TaiMed Biologics Inc. | 225.23 Million TWD | 97.658% |
| GlycoNex Incorporation | 995 Thousand TWD | -430.05% |
| VBI | 32.55 Million TWD | 83.8% |
| GeneReach Biotechnology Corp. | 256.86 Million TWD | 97.947% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 194.18 Million TWD | 97.284% |
| SynCore Biotechnology Co.,Ltd | 46.02 Million TWD | 88.541% |
| Genomics BioSci & Tech. Co.,Ltd. | 119.91 Million TWD | 95.602% |
| Visgeneer Inc. | 67.48 Million TWD | 92.185% |
| Mycenax Biotech Inc. | -375.19 Million TWD | 101.406% |
| Sunmax Biotechnology Co., Ltd. | 510.09 Million TWD | 98.966% |
| G&E Herbal Biotechnology Co., Ltd. | 63.9 Million TWD | 91.747% |
| Neith Corporation | 66.87 Million TWD | 92.113% |
| Medigen Vaccine Biologics Corporation | 1.44 Billion TWD | 99.635% |
| TaiwanJ Pharmaceuticals Co., Ltd. | 29.35 Million TWD | 82.032% |
| Enimmune corporation | 220.1 Million TWD | 97.604% |
| TaiRx, Inc. | 217.13 Million TWD | 97.571% |
| CHO Pharma, Inc. | 268.99 Million TWD | 98.039% |
| EirGenix Inc. | 236.74 Million TWD | 97.772% |
| BioLASCO Taiwan Co., Ltd. | 104.35 Million TWD | 94.946% |
| Sunny Pharmtech Inc. | 357.62 Million TWD | 98.525% |
| Lin BioScience, Inc. | 1.09 Billion TWD | 99.519% |
| BioGend Therapeutics Co., Ltd. | 266.15 Million TWD | 98.018% |
| Feng Chi Biotech Corp. | 49.47 Million TWD | 89.339% |
| Bio Preventive Medicine Corp. | 1.08 Million TWD | -386.981% |
| Lukas Biomedical Inc. | 177.45 Million TWD | 97.028% |
| RBC Bioscience Corporation | 58.35 Million TWD | 90.962% |
| BiOptic Inc. | 108.69 Million TWD | 95.148% |
| BRIM Biotechnology, Inc. | 90 Thousand TWD | -5760.0% |
| Shine-On BioMedical Co.,Ltd. | 69.35 Million TWD | 92.395% |
| Great Novel Therapeutics Biotech & Medicals | 2.61 Million TWD | -101.683% |
| Syngen Biotech Co.,Ltd. | 643.91 Million TWD | 99.181% |
| Advagene Biopharma Co., Ltd. | 93.33 Million TWD | 94.349% |
| NaviFUS Corp. | 11.82 Million TWD | 55.407% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 190.72 Million TWD | 97.235% |
| Sinew Pharma Inc. | 186.25 Million TWD | 97.168% |
| Andros Pharmaceuticals Co.,Ltd | 74.02 Million TWD | 92.875% |
| Greenyn Biotechnology Co., Ltd | 220.39 Million TWD | 97.607% |
| Lumosa Therapeutics Co., Ltd. | 41.48 Million TWD | 87.286% |
| AP Biosciences Inc | 32.25 Million TWD | 83.648% |
| Medigen Biotechnology Corp. | 1.85 Billion TWD | 99.715% |
| Pharmosa Biopharm Inc. | 317.32 Million TWD | 98.338% |
| Intech Biopharm Corporation | -163.99 Million TWD | 103.216% |
| Oneness Biotech Co., Ltd. | 1.12 Billion TWD | 99.533% |
| Eusol Biotech Co.,Ltd. | 41.48 Million TWD | 87.286% |
| TWi Biotechnology, Inc. | 169.55 Million TWD | 96.89% |
| Ever Supreme Bio Technology Co., Ltd | 147.02 Million TWD | 96.413% |
| TCI GENE Inc. | 174.61 Million TWD | 96.98% |
| MegaPro Biomedical Co., Ltd | 18 Thousand TWD | -29200.0% |
| Senhwa Biosciences, Inc. | 300.93 Million TWD | 98.247% |
| Taiwan Bio Therapeutics Co., Ltd | 290.95 Million TWD | 98.187% |
| NatureWise Biotech & Medicals Corporation | 83.94 Million TWD | 93.717% |
| PharmaEngine, Inc. | 441.78 Million TWD | 98.806% |
| Savior Lifetec Corporation | 223.36 Million TWD | 97.639% |
| TaiGen Biopharmaceuticals Holdings Limited | 258.77 Million TWD | 97.962% |
| OBI Pharma, Inc. | 2.01 Billion TWD | 99.738% |
| Meribank Biotech Co., Ltd | 138.87 Million TWD | 96.202% |
| Acepodia, Inc. | 452.56 Million TWD | 98.835% |
| Caliway Biopharmaceuticals Co., Ltd. | 540.93 Million TWD | 99.025% |